Abstract
The effects of BN 52021, a new specific paf-acether receptor antagonist and the total Ginkgo biloba extract (GBE 761) from which this product was isolated, were studied in the rat on paf-acether-induced permeability and cell number changes and on endotoxin-induced lethality.
Their activities were compared to those of cycloxygenase, 5-lipoxygenase and phospholipase A2 inhibitors. BN 52021 given s.c. or orally exerted a dose-related inhibition of paf-acether deleterious effects as well as of endotoxin lethality whereas the other drugs tested were poorly effective. These results strongly suggest paf-acether involvement in endotoxic and septic shock.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
D. Lundberg, K. Alestig, U. Haglund, A. Hellman,Intensive care treatment in septic shock, Scand. J. Infect. Dis., Suppl.41, 187–191 (1983).
M.C. Houston, W.L. Thompson andD. Robertson,Shock diagnosis and management, Arch. Intern. Med.144 (7), 1433–1439 (1984).
B.L. Furman, K. McKechnie andJ.R. Parratt,Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats, Br. J. Pharmac.82, 289–294 (1984).
P.G. Braquet,Treatment and prevention of paf-acether-induced sickness by a new series of highly specific inhibitors, G.B. Patent 8, 418–424 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Etienne, A., Hecquet, F., Soulard, C. et al. In vivo inhibition of plasma protein leakage andSalmonella enteritidis—induced mortality in the rat by a specific paf-acether antagonist: BN 52021. Agents and Actions 17, 368–370 (1986). https://doi.org/10.1007/BF01982649
Issue Date:
DOI: https://doi.org/10.1007/BF01982649